Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Beyond Air, Inc. (XAIR) Separates Cancer Business into Beyond Cancer
-
Robinhood (HOOD) announces way to facilitate meaningful, community-driven access to IPOs
-
89bio Inc. (ETNB) Announces Appointment of Kathy LaPorte to its Board of Directors
-
Stanford Medicine Earns Top Ranking for Quality, Safety From Vizient
-
F45 Training Holdings Inc. (FXLV) Announces Partnership with Royal Caribbean
-
ClearPoint Neuro Inc. (CLPT) Appoints Linda M. Liau to its Board
-
BridgeBio Pharma Inc. (BBIO) Collaborates with Columbia University and Mount Sinai to Develop Potential Therapies for Genetic Diseases and Cancers
-
BridgeBio Pharma Inc. (BBIO) Appoints Hannah Valantine to its Boar
-
Frontdoor, Inc. (FTDR) Appoints Christopher Clipper to its Board
-
urban-gro Inc. (UGRO) Appoints Sonia Lo to its Board
-
Wine.com Adds Industry Veterans to Merchandising Team to Support Growth
-
Wine.com Adds Industry Veterans to Merchandising Team to Support Growth
-
SpringWorks Therapeutics (SWTX) to Collaborate with Leading Academic Institutions to Advance Portfolio of Next-Generation Mutation-Selective EGFR Inhibitors
-
Altra Industrial Motion (AIMC) Appoints La Vonda Williams to its Board
-
TG Therapeutics (TGTX) Announces Data for Ublituximab in MS Presented at ECTRIMS
-
Sunnova Energy International Inc. (NOVA) Appoints Mary Yang to Its Board
-
TRACON Pharmaceutical (TCON) Appoints Carol Lam to its Board
-
Dyne Therapeutics Inc. (DYN) Highlights Preclinical Data and Clinical Development Plans for DMD and DM1 Programs
-
Spero Therapeutics (SPRO) Appoints Kathleen Tregoning to its Board
-
BridgeBio Pharma (BBIO) Announces Progress in its KRAS Portfolio, New Gene Therapy Programs, and Updates on Advancements Across its R&D Pipeline
-
PPL Corp. (PPL) Appoints Heather B. Redman to its Board
-
Stanford Health Care Honored for Technology That Improves Patient Care
-
Big 5 Sporting Goods (BGFV) Appoints Lily W. Chang to Its Board
-
KKR & Co. (KKR) Appoints Evan Spiegel as New Independent Director
-
General Motors (GM) Appoints Aneel Bhusri to its Board
-
Pulse Biosciences, Inc. (PLSE) Appoints Laureen DeBuono to Its Board
-
NextCure Inc. (NXTC) Appoints Ellen G. Feigal and Anne Borgman to its Board
-
TG Therapeutics (TGTX) Submits BLA to FDA for Ublituximab as Treatment for Patients with Relapsing Forms of Multiple Sclerosis
-
Coherus BioSciences (CHRS) Mourns the Passing of Board Member Dr. Samuel Nussbaum
-
TG Therapeutics (TGTX) to Present Data from ULTIMATE I & II Phase 3 Trials of Ublituximab in MS at ECTRIMS
-
Geovax Labs Inc. (GOVX) Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
-
Immunogen (IMGN) Appoints Helen M. Thackray to its Board
-
Medicenna Therapeutics (MDNA) Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 Program
-
Celltrion Healthcare and 180 Life Sciences (ATNF) Enter MOU for Supply Agreement for Ongoing Supply of Drug for Anti-TNF Product Trials for Novel Indications
-
BeyondSpring (BYSI) Announces New Positive Data on Plinabulin from Its Chemotherapy-Induced Neutropenia Prevention Program at the European Society for Medical Oncology 2021 Congress
-
Toll Brothers (TOL) Announces Promotion of Robert Parahus to President & COO; James W. Boyd, current Co-COO, to Retire After 30 Years with the Company
-
Stanford professors urge U.S. to end program looking for Chinese spies in academia
-
DaVita (DVA) Appoints Gregory Moore to its Board
-
Beyond Meat (BYND) Rival Impossible Foods Launches Chicken Nuggets Made From Plants
-
Phunware (PHUN) Appoints Ryan Costello and Rahul Mewawall to its Board
-
Instructure (INST) Appoints Ossa Fisher and Lloyd "Buzz" Waterhouse to its Board
-
Adamis Pharmaceuticals (ADMP) Doses First Patients in Phase 2/3 Trial of Tempol to Treat COVID-19
-
Performance Food Group (PFGC) Appoints Laura Flanagan to its Board
-
Cidara Therapeutics (CDTX) Appoint Preetam Shah as CFO and CBO, and Shane Ward as Chief Legal Officer and Corporate Secretary
-
Lordstown Motors (RIDE) Appoints Daniel A. Ninivaggi as Chief Executive Officer
-
Eli Lilly & Co. (LLY) Announces Resignation of Carolyn Bertozzi from Board
-
FactSet (FDS) Appoints Linda S. Huber as CFO
-
Adamis Pharmaceuticals (ADMP) Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient’s Cell
-
Vaxart (VXRT) Appoints Julie M. Cherrington to its Board
-
Chart Industries (GTLS) Appoints Paula Harris, Linda Harty and Roger Strauch to its Board

